Insights

January is One Health Awareness Month, when we promote the importance of public, animal, and environmental health. Learn about how CLSI has promotes the values of the One Health Initiative through its AST subcommittees that establish testing standards for the human and veterinary laboratory sectors.

In January of each year CLSI publishes M100—Performance Standards for Antimicrobial Susceptibility Testing. M100 reports the antibiotic breakpoints that help medical laboratorians throughout the world provide accurate test results to health care providers. These breakpoints aid laboratorians in selecting the most appropriate and effective antimicrobial treatments for patients.

Presented by CLSI, read the article, “The Antibiotic Resistance Laboratory Network (AR Lab Network) – Bridging the Gap by Offering Expanded Antimicrobial Susceptibility Testing,” byPaula Snippes Vagnone, AR Lab Network Central Region Lab Coordinator, Minnesota Department of Health, Public Health Laboratory, St. Paul, MN.

The CDC is reporting that Candida auris, an emerging fungus, presents a serious global health threat, causing severe illness in hospitalized patients.

CLSI raises awareness of Clostridium difficile infections this November. Clostridium difficile infections in the community appear to be rising. Learn more.

A forgotten antibiotic has shown promise in treating antimicrobial resistant bacteria.

Find the answer to "When Should Clinical Microbiology Laboratories Perform Carbapenemase Detection Tests?"

This article features a case study on the direct detection of MRSA/MSSA from positive blood cultures.

CLSI has been on the front line of the fight against antimicrobial resistance since its earliest days, over 35 years ago. Learn more about CLSI's work.

Antimicrobial resistance is one of the most serious global health threats in the world.